
Billionaire In-N-Out Burger Heiress Moves Out of California
In-N-Out Burger's president and owner is moving her family out of the state where the burger chain began.
Lynsi Snyder, 43, who has been president of In-N-Out since 2010, sat down for an episode of the podcast "Relatable," and said that she and her family are moving from her home state of California to Tennessee, where In-N-Out is opening a new office.
"We're building an office, so I'm actually moving out there," Snyder said on the podcast that aired on Friday. "There [are] a lot of great things about California, but raising a family is not easy here. Doing business it's not easy here now."
Related: Forget the Six-Figure UPS Gig. You Can Make $180,000 at In-N-Out, Writes Burger Heiress Lynsi Snyder in Her New Book.
In January 2023, In-N-Out announced that it's opening its first East Coast restaurant in Nashville, Tennessee, and building its first East Coast headquarters about 20 miles away in Franklin, which will cost $125 million to construct. The burger chain plans to spread across Tennessee, expanding to Chattanooga, Knoxville, and Memphis, opening more than a dozen locations.
In-N-Out is also opening new locations in Arizona, California, and Colorado this year and debuting its first location in Washington.
Snyder, who grew up in Northern California, said on the podcast that "the bulk" of In-N-Out stores are still going to be in the state, but that she is looking forward to having more of a footprint in Tennessee.
"It will be wonderful having an office out there, growing out there, and being able to have the family and other people's families out there," Snyder said on the podcast.
In-N-Out will also be consolidating its two existing California corporate offices, moving its Irvine headquarters to Baldwin Park, where the first In-N-Out location opened in the 1940s. Snyder disclosed on the podcast that the Irvine office will close by 2030 to complete the consolidation.
According to the California Department of Justice, the violent crime rate in the state increased 15.1% from 2018 to 2023. According to Statista, around 3,640 violent crimes per 100,000 residents were reported in Oakland, California, in 2023, making Oakland the most dangerous city in the U.S. that year. Snyder said last year that rising crime and "absolutely dangerous" conditions caused In-N-Out to shut down a restaurant in Oakland in March 2024, marking the first time in the burger chain's 77-year history that it had to shutter a restaurant.
Snyder said that the company closed the profitable Oakland location "for the safety of our associates," adding that "gunshots went through the store, there was a stabbing, there was a lot."
Related: In-N-Out Burger Is Opening New Locations Outside of California — Here's Where It's Going Next
Snyder's grandparents, Harry and Esther Snyder, founded In-N-Out in 1948 as a single drive-thru hamburger restaurant in Baldwin Park, California. Today, the company has grown to more than 400 locations that bring in $2.1 billion a year, according to consulting firm Technomic.
Snyder took over In-N-Out in 2017 at age 35 when she received the final portion of her inheritance that gave her 97% ownership of the company. She became one of the world's youngest billionaires in the process.
In-N-Out differentiates itself from competitors by vowing to never freeze ingredients and crafting fresh-to-order burgers. The company has also never franchised, remaining privately owned.
According to the Bloomberg Billionaires Index, Snyder has a net worth of $7.32 billion, making her the 483rd richest person in the world.
Join top CEOs, founders and operators at the Level Up conference to unlock strategies for scaling your business, boosting revenue and building sustainable success.
Related: In-N-Out Burger Is Moving East. Is It Coming to Your State?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
7 minutes ago
- Yahoo
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio